Skip to main content Accessibility help

Antidepressants in the 1990s

  • Eugene S. Paykel
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antidepressants in the 1990s
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Antidepressants in the 1990s
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Antidepressants in the 1990s
      Available formats


  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.


Corresponding author

Indirizzo per la corrispondenza: Professor E.S. Paykel, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ (UK).


Hide All
American Psychiatric Association (1993). Practice guidelines for major depressive disorder in adults. American Journal of Psychiatry 150, Suppl. 4, 126.
Berman, R.M., Darnell, A.M., Miller, H.L., Anand, A. & Charney, D.S.. (1997). Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double blind, placebo-controlled trial. American Journal of Psychiatry 154, 3743.
Blier, P., de Montigny, C. & Chaput, Y. (1987). Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. Journal of Clinical Psychopharmacology 7, Suppl. 6, 245355.
Bordet, R., Thomas, P. & Dupuis, B. (1997). Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. American Journal of Psychiatry 155, 13461351.
Brodaty, H., Harris, L., Peters, K., Wilhelm, K., Hidkie, I., Boyce, P., Mitchell, P., Parker, G. & Eyers, K. (1993). Prognosis of depression in the elderly: a comparison with younger patients. British Journal of Psychiatry 163, 589596.
Davidson, J., Pleton, S., Krishnan, R.R. & Allf, B. (1986). The Newcastle Anxiety Depression Index in relationship to the effects of MAOI and TCA drugs. Journal of Affective Disorders 11, 5161.
Den Boer, J.A. & Westenberg, H.G.M. (1988). Effect of serotonin and noradrenaline uptake inhibitors in panic disorders: a double-blind comparative study with fluvoxamine and maprotiline. International Journal of Clinical Psychopharmacology 3, 5974.
Evans, L., Kenardy, J., Schneider, P. & Hoey, H. (1986). Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Acta Psychiatrica Scandinavica 73, 4953.
Faedda, G.L., Tondon, L., Baldessarini, R.J., Suppes, T. & Tohen, M. (1993). Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Archives of General Psychiatry 50, 448455.
Fava, G.A., Rafanelli, C., Grandi, S., Canestrari, R. & Morphy, M.A. (1998). Six year outcome for cognitive behavioural treatment of residual symptoms in major depression. American Journal of Psychiatry 155, 14431445.
Goodman, W.K., Price, L.H., Delgado, P.L., Palumbo, J., Krystal, J.H., Nagy, L.M., Rasmussen, S.A., Heninger, G.R. & Charney, D.S. (1990). Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry 47, 577585.
Keller, M.B., Klerman, G.L., Lavori, P.W., Coryell, W., Endicott, J. & Taylor, J.. (1984). Long-term outcome of episodes of major depression: clinical and public health significance. Journal of the Ame-rican Medical Association 252, 788792.
Kiloh, L.G., Andrews, G.A. & Neilson, M. (1988). The long-term out-come of depressive illness. British Journal of Psychiatry 153, 752757.
Kramer, M.S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J.J., Reines, S.A., Liu, G., Snavely, D., Wyatt-Knowles, E., Hale, J.J., Mills, S.G., MacCoss, M., Swain, C.J., Harrison, T., Hill, R.G., Hefti, F., Scolnick, E.M., Cascieri, M.A., Chicchi, G.G., Smith, D., Carlson, E.J., Hargreaves, R.J. & Rupniak, N.M.J. (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 16401645.
Kupfer, D.J. (1991). Long-term treatment of depression. Journal of Clinical Psychiatry 52, Suppl. May, 2834.
Lee, A.S. & Murray, R.M.. (1988). The long-term outcome of Maudsley depressives. British Journal of Psychiatry 153, 741751.
Leonard, H., Swedo, S., Rapoport, J.L., Coffey, M. & Cheslow, D. (1988). Treatment of childhood obsessive-compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psychopharmacological Bulletin 24, 9395.
Liebowitz, W.R., Quitkin, F.M., Stewart, J.W., McGrath, P., Harrison, W.M., Markowitz, J.A., Rabkin, J.G., Tricamo, E., Goetz, D.M. & Klein, D.F. (1988). Antidepressant specificity in atypical depression. Archives of General Psychiatry 45, 129137.
Maes, M., Vandoolaeghe, E. & Desnyder, R. (1996). Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. Journal of Affective Disorders 41, 201210.
Paykel, E.S. (1995). Clinical efficacy of reversible and selective inhibitors of monamine oxidase A in major depression. Acta Psychiatrica Scandinavica 91, Suppl. 386, 2227.
Paykel, E.S. (1996). Tertiary prevention: longer-term drug treatment in depression. In The Prevention of Mental Illness in Primary Care (ed. Kendrick, T., Tylee, A. and Freeling, P), pp. 281293. Cambridge University Press: Cambridge.
Paykel, E.S. & Priest, R.G. (1992). Recognition and management of depression in general practice: consensus statement. British Medical Journal 305, 11981202.
Paykel, E.S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J. & Barocka, A. (1995). Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine 25, 11711180.
Paykel, E.S., Rowan, P.R., Parker, R.R. & Bhat, A.V. (1982). Response to phenelzine and amitriptyline in subtypes of outpatient depression. Archives of General Psychiatry 39, 10411049.
Paykel, E.S., Parker, R.R., Rowan, P.R., Rao, B.M. & Taylor, C.N. (1983). Nosology of atypical depression. Psychological Medicine 13, 131139.
Paykel, E.S., Hollyman, J.A., Freeling, P. & Sedgwick, P. (1988). Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. Journal of Affective Disorders 14, 8395.
Paykel, E.S., Tylee, A., Wright, A., Priest, R.G., Rix, S. & Hart, D. (1997). The Defeat Depression Campaign: psychiatry in the public arena. American Journal of Psychiatry 154, Suppl. 6, 5965.
Paykel, E.S., Hart, D. & Priest, R.G.. (1998). Changes in public attitudes to depression during the Defeat Depression Campaign. British Journal of Psychiatry 173, 519522.
Paykel, E.S., Scott, J., Teasdale, J.D., Johnson, A.L., Garland, A., Moore, R., Jenaway, A., Cornwall, P.L., Hayhurst, H., Abbott, R. & Pope, M. (1999). Prevention of relapse by cognitive therapy in residual depression: a controlled trial. Archives of General Psychiatry 56, 829835.
Perez, V., Gilaberte, I., Faries, D., Alvarez, E. & Artigas, F. (1997). Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349, 15941597.
Perez, V., Soler, J., Puigdemont, D. & Alvarez, E. (1999). A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Archives of General Psychiatry 56, 375379.
Quitkin, F.M., Steward, J.W., McGrath, P.J., Liebowitz, J.R., Harrison, W.M., Tricamo, E., Klein, D.F., Rabkin, J.G., Wager, S. & Markowitz, J. (1988). Phenelzine versus imipramine in the treatment of probably atypical depression: defining syndrome boundaries of selective MAOI responders. American Journal of Psychiatry 145, 306311.
Quitkin, F.M., McGrath, P.J., Stewart, J.W., Harrison, W., Tricamo, E., Wager, S.G., Ocepek-Welikson, K. & Nunes, E. (1990). Atypical depression, panic attacks and response to imipramine and phenelzine. Archives of General Psychiatry 47, 935941.
Ramana, R., Paykel, E.S., Surtees, P.G., Melzer, D. & Mehta, M. (1999). Medication received by patients with depression following the acute episode: adequacy and relation to outcome. British Journal of Psychiatry 174, 128134.
Ravaris, C.L., Robinson, D.S., Ives, J.O., Nies, A. & Bartlett, D. (1980). Phenelzine and amitriptyline in the treatment of depression. Archives of General Psychiatry 37, 10761080.
Rosenbaum, J.F., Fava, M., Hong, S.L., Ascroft, R.C. & Krebs, W. (1998). Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry 44, 7787.
Sasson, Y.Iancu, I., Fux, M., Taub, M., Dannon, P.N. & Zohar, J. (1999). A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder. European Neuropsychopharmacology 9, 191196.
Sheehan, D., Ballenger, J. & Jacobsen, G. (1980). Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Archives of General Psychiatry 36, 5159.
Smeraldi, E., Benedetti, F., Barbini, B., Campori, E. & Colombo, C. (1999). Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression: a placebo controlled trial. Neuropsychopharmacology 20, 380385.
Stewart, J.W., Quitkin, F., Liebowitz, M.R., McGrath, P.J., Harrison, W., & Klein, D.F. (1983). Efficacy of desipramine in depressed outpatients: response according to Research Diagnostic Criteria and severity of illness. Archives of General Psychiatry 40, 202207.
Suppes, T., Baldessarini, R.J., Faedda, G.L. & Tohen, M. (1991). Risk of recurrence following discontinuation of lithium treatment in bi-polar disorder. Archives of General Psychiatry 48, 10821088.
Thoren, P., Asberg, M., Cronholm, B., Jornested, T.L. & Traskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder 1: a controled clinical trial. Archives of General Psychiatry 37, 12811285.
Tome, M.B., Isaac, M.T. & Holland, C. (1997). Paroxetine and pindolol: a randomised trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. International Clinical Psychopharmacology 12, 8189.
West, E.D. & Dally, P.J. (1959). Effects of iproniazid in depressive syndromes. British Medical Journal 1, 14911499.
Zanardi, R., Artigas, F., Franchini, L., Sforzini, L., Gasperini, M., Semraldi, E. & Perez, J. (1997). How long should pindolol be associated with paroxetine to improve the antidepressant response? Journal of Clinical Psychopharmacology 17, 446450.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed